These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1381816)

  • 1. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.
    Green AR; De Souza RJ; Williams JL; Murray TK; Cross AJ
    Neuropharmacology; 1992 Apr; 31(4):315-21. PubMed ID: 1381816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
    Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlormethiazole and dizocilpine block the behavioural, but not the neurotoxic effects of 5,7-dihydroxytryptamine in mice.
    Snape MF; Colado MI; Green AR
    Pharmacol Toxicol; 1994 Jan; 74(1):40-2. PubMed ID: 7512715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.
    Ali SF; Newport GD; Slikker W
    Ann N Y Acad Sci; 1996 Oct; 801():187-98. PubMed ID: 8959033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice.
    Ali SF; Newport RR; Holson W; Slikker W; Bowyer JF
    Ann N Y Acad Sci; 1995 Sep; 765():338. PubMed ID: 7486639
    [No Abstract]   [Full Text] [Related]  

  • 9. Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study.
    Thaminy S; Reymann JM; Heresbach N; Allain H; Lechat P; Bentué-Ferrer D
    Pharmacol Biochem Behav; 1997 Apr; 56(4):737-45. PubMed ID: 9130301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists.
    MacGregor DG; Graham DI; Stone TW
    Exp Neurol; 1997 Nov; 148(1):110-23. PubMed ID: 9398454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
    Hewitt KE; Green AR
    Neuropharmacology; 1994 Dec; 33(12):1589-95. PubMed ID: 7539115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.
    Gluck MR; Moy LY; Jayatilleke E; Hogan KA; Manzino L; Sonsalla PK
    J Neurochem; 2001 Oct; 79(1):152-60. PubMed ID: 11595767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
    Miller DB; O'Callaghan JP
    Ann N Y Acad Sci; 1993 May; 679():321-4. PubMed ID: 8099774
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
    Weihmuller FB; O'Dell SJ; Marshall JF
    Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.
    Cadet JL; Ali S; Epstein C
    Ann N Y Acad Sci; 1994 Nov; 738():388-91. PubMed ID: 7530424
    [No Abstract]   [Full Text] [Related]  

  • 20. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum.
    Muraki A; Koyama T; Nakayama M; Ohmori T; Yamashita I
    Neurosci Lett; 1992 Feb; 136(1):39-42. PubMed ID: 1353257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.